Cannabis and the Heart: Cardiovascular Risks You Need to Know
From tachycardia to myocardial infarction — the evidence on cannabis and cardiac health
Cannabis is widely perceived as a low-risk substance, but its cardiovascular effects are significant and underappreciated — particularly for older adults and those with pre-existing cardiac disease. This review covers the acute and chronic cardiovascular effects of cannabis, the mechanisms behind them, and who is most at risk.
Acute Cardiovascular Effects of THC
THC produces significant acute cardiovascular effects through both central and peripheral mechanisms. The most consistent finding is tachycardia: THC increases heart rate by 20–100% above baseline within minutes of use, peaking at 10–30 minutes and lasting 2–3 hours. The mechanism involves CB1 receptor activation in the brainstem and sympathetic ganglia, causing increased sympathetic tone and vagal inhibition. Blood pressure shows a biphasic response — an initial modest increase followed by orthostatic hypotension, particularly when standing.
These hemodynamic changes increase cardiac workload (the product of heart rate and blood pressure, known as the "double product") — a key determinant of myocardial oxygen demand. In healthy young adults, this increased workload is well-tolerated. In patients with coronary artery disease, reduced coronary reserve, or heart failure, the same hemodynamic changes can precipitate angina, myocardial infarction, or acute decompensation.
Cannabis and Myocardial Infarction Risk
The most alarming cardiovascular finding in cannabis research is the acute elevation in myocardial infarction (MI) risk. A landmark 2001 study by Mittleman et al. (Circulation, n=3,882 MI patients) found that cannabis use increased MI risk 4.8-fold in the 60 minutes after use, compared to periods of non-use. The risk was highest in older patients and those with pre-existing coronary disease.
A 2019 analysis of the National Inpatient Sample (n=>2.4 million) found cannabis use associated with a 1.5-fold increased risk of MI hospitalization, independent of tobacco use. Case reports document MI in young adults (20s–30s) with no other risk factors following cannabis use. The proposed mechanisms include coronary vasospasm (cannabis can trigger coronary artery spasm), platelet activation, and the hemodynamic stress of tachycardia in the setting of increased myocardial oxygen demand.
Arrhythmias and Sudden Cardiac Death
Cannabis use has been associated with multiple cardiac arrhythmias in case reports and observational studies. Atrial fibrillation (AF) is the most commonly reported: a 2019 systematic review identified 34 case reports of cannabis-associated AF, predominantly in young adults. A large Danish registry study found cannabis users had a 35% higher risk of AF hospitalization.
More serious arrhythmias — ventricular tachycardia, ventricular fibrillation, and Takotsubo (stress) cardiomyopathy — have been reported in case series, though the absolute risk is low. The mechanism likely involves CB1 receptor activation in cardiac tissue, which modulates ion channel function and can alter the cardiac action potential. High-potency cannabis and synthetic cannabinoids (which have much higher CB1 affinity than THC) carry substantially higher arrhythmia risk.
Chronic Cardiovascular Effects
The chronic cardiovascular effects of cannabis are less well-characterized than the acute effects. Long-term heavy cannabis smoking is associated with increased atherosclerosis progression in some studies, though the contribution of co-occurring tobacco use is difficult to separate. Cannabis-associated arteritis — a rare but serious condition causing peripheral vascular disease in young adults — has been described in case series, predominantly in heavy users.
A 2020 analysis of the NHANES dataset found that daily cannabis users had higher rates of hypertension, coronary artery disease, and stroke than non-users, even after adjusting for tobacco use and other confounders. However, the observational nature of this data limits causal inference. Notably, CBD does not appear to share THC's acute cardiovascular effects — CBD has no significant effect on resting heart rate or blood pressure at therapeutic doses, and may have mild antihypertensive effects.
Who Is Most at Risk?
The cardiovascular risks of cannabis are not uniformly distributed. Highest-risk groups include: (1) Adults over 55 — the 4.8-fold MI risk from Mittleman et al. was concentrated in this age group; (2) Patients with established coronary artery disease, heart failure, or significant arrhythmias; (3) Those with uncontrolled hypertension; (4) Patients using cannabis concurrently with other sympathomimetic substances (cocaine, amphetamines); (5) Users of high-potency products (>20% THC) or synthetic cannabinoids.
For young, healthy adults without cardiac risk factors, the absolute cardiovascular risk from occasional cannabis use is low. The risk-benefit calculation changes substantially with age, cardiac history, and frequency of use. Clinicians should routinely ask about cannabis use when evaluating patients with unexplained tachycardia, chest pain, or arrhythmia.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making treatment decisions. See our editorial standards.